A Multicenter Clinical Study on the Continuous vs. Intermittent Infusion of Ceftazidime-Avibactam in Critically Ill Patients With Severe Infections

Clinical trial NCT06939829 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06939829
Sponsor: Southeast University, China
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Patients With Critically Ill Infections

Start date: 2025-05-01
Primary completion: 2027-12-31
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.